文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌SBRT中间隔水凝胶形态的次间监测

Interfractional Monitoring of Spacer Hydrogel Morphology in Patients With Prostate Cancer Receiving SBRT Treatment.
PubMed 文献 · Pract Radiat Oncol · 2026-08-07

本研究纳入198例在前列腺SBRT前接受间隔水凝胶并通过MR-Linac治疗的患者,利用U-Net深度学习模型纵向监测水凝胶形态变化。结果显示水凝胶整体几何形态在5次分次治疗中保持稳定,无显著吸收证据,但平坦度指标轻微增加,且治疗影像中水凝胶体积平均增加10.62%。

要点

  • 水凝胶整体几何形态在5次SBRT分次中保持稳定。
  • 平坦度每10天增加0.003单位,形状略变圆。
  • 治疗影像中水凝胶体积平均增加10.62%。

核心结论

  • 水凝胶在前列腺SBRT的5次分次治疗中保持直肠保护构型,整体几何形态稳定。

研究设计与样本

  • 单中心研究纳入2023年10月至2025年3月接受前列腺SBRT的198例患者,每例至少1次模拟MRI和5次治疗中MRI。
  • 使用nnUNetv2构建U-Net深度学习模型,迭代训练后Dice相似系数>0.98,用于检测水凝胶形态随时间的变化。

主要发现

  • 纵向建模显示平坦度变化具有统计学意义,每10天增加0.003单位(95%CI 0.001-0.005;FDR q≈0.02),提示形状逐渐变圆。
  • 治疗影像中水凝胶体积平均增加10.62%(95%CI 8.68%-12.56%;P<.001),绝对体积差为1.19 cm³(95%CI 1.00 cm³-1.39 cm³;P<.001)。
  • 其他影像组学形状特征变化微小或不一致。

关键数值与推荐

  • 模拟定位与首次治疗平均间隔约19.9天,与末次治疗平均间隔约31.1天,治疗间间隔2至3天。

临床怎么用

  • 前列腺SBRT计划假设水凝胶稳定,次间变化可能影响直肠剂量估算,需关注水凝胶形态的纵向变化。
  • 本队列中水凝胶未出现有意义的吸收,直肠保护配置在整个SBRT疗程中得以维持。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study is to explore whether spacer hydrogel morphology changes during the course of stereotactic body radiation therapy (SBRT) radiation to the prostate. METHODS AND MATERIALS: A total of 198 patients at our institution each received spacer gel before SBRT on magnetic-resonance-guided linear accelerator (MR-Linac) between October 2023 and March 2025. Each patient received at least 1 simulation magnetic resonance imaging and 5 on-treatment magnetic resonance imaging scans. Average time between simulation and first treatment and between simulation and final treatment was approximately 19.9 days and 31.1 days, respectively, with 2- to 3-day intervals between treatments. A U-Net deep learning model was implemented using nnUNetv2. This model was iteratively trained using inference images, resulting in a Dice similarity coefficient >0.98, and was then applied to detect changes in gel morphology over time. RESULTS: Longitudinal modeling of spacer gel radiomic shape features demonstrated a statistically significant change in flatness that remained significant over false discovery rate correction and all sensitivity analyses. This metric increased by 0.003 units per 10 days (95% CI, 0.001-0.005; false discovery rate q ≈ 0.02), implying a progressively rounder shape over the observation period. All other features showed minimal or inconsistent change. The hydrogel appeared larger on treatment imaging, with a mean percent change of 10.62% (95% CI, 8.68%-12.56%; P < .001). The corresponding absolute volume difference was 1.19 cm³ (95% CI, 1.00 cm³-1.39 cm³; P < .001). CONCLUSIONS: Because prostate SBRT planning assumes gel stability, interfractional changes could affect rectal dose estimates. In this cohort, the spacer hydrogel's overall geometry remained stable across the 5-fraction course, with no meaningful evidence of gel resorption. A small increase in the flatness metric was observed, but without a change in size or compactness. These findings indicate that the gel maintains its rectal-sparing configuration throughout SBRT.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Koduri S, Barbee D, Oh C, et al. Interfractional Monitoring of Spacer Hydrogel Morphology in Patients With Prostate Cancer Receiving SBRT Treatment. Pract Radiat Oncol. 2026. PMID: 42565768. doi:10.1016/j.prro.2026.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。